No open-market buys or sells in this period. The transactions below are grants, option exercises and gifts, which carry no market price.
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
LGVN Grant·A
Chief Medical Officer
$0
250.0K sh
Own +123%
-
LGVN Other·F
Chief Medical Officer
$14.7K
13.1K sh · $1.12
Own -6%
-
LGVN Other·F
Chief Medical Officer
$6.0K
10.2K sh · $0.59
Own -5%
-
LGVN Other·F
Chief Medical Officer
$8.8K
11.9K sh · $0.74
Own -5%
-
LGVN Grant·A
Chief Medical Officer
$0
34.0K sh
Own New
-
LGVN Grant·A
Chief Medical Officer
$0
102.0K sh
Own +75%
-
LGVN Other·F
Chief Medical Officer
$9.5K
7.4K sh · $1.28
Own -5%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| May 1, 2026 | LGVN | Grant A | 250.0K | $0 |
| Apr 1, 2026 | LGVN | Other F | 13.1K | $14.7K |
| Jan 2, 2026 | LGVN | Other F | 10.2K | $6.0K |
| Oct 1, 2025 | LGVN | Other F | 11.9K | $8.8K |
| Jul 15, 2025 | LGVN | Grant A | 34.0K | $0 |
| Jul 15, 2025 | LGVN | Grant A | 102.0K | $0 |
| Jul 1, 2025 | LGVN | Other F | 7.4K | $9.5K |
Buy Sell Non-market (grant · exercise · gift)
About Agafonova Nataliya
This profile aggregates every SEC Form 4 insider transaction reported by Agafonova Nataliya across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.